LLY
Eli Lilly and Company · NYSE
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website lilly.com
- Employees(FY) 39000
- ISIN US5324571083
Performance
-0.04%
1W
+3.29%
1M
-1.38%
3M
+31.23%
6M
+32.54%
YTD
+77.3%
1Y
Profile
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; Foghorn Therapeutics Inc., and PRISM BioLab Co.,Ltd. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Investment Analysis Report: Eli Lilly and Company (LLY)
Overview:
Eli Lilly and Company (LLY) is a major player in the pharmaceutical industry with a market capitalization of $731.19 billion. The company operates in the Health Technology sector and specializes in Pharmaceuticals. In this report, we will conduct a detailed analysis of LLY's finan...
Technical Analysis of LLY 2024-05-10
Overview:
In analyzing the technical indicators for LLY over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions for informed decis...
Recent News & Updates
- 2024-05-18 03:02
- 2024-05-18 02:44
- 2024-05-17 23:57
- 2024-05-17 21:00
- 2024-05-17 15:29
- 2024-05-17 11:57
- 2024-05-17 11:39
- 2024-05-17 10:04
- 2024-05-17 09:00
- 2024-05-17 08:24
- 2024-05-17 06:31
Eli Lilly’s efsitora alfa shows promise in Phase III T2D trials(Clinical Trials Arena)
- 2024-05-17 05:32
- 2024-05-17 05:23
- 2024-05-17 02:55
- 2024-05-16 20:13
- 2024-05-16 20:11
- 2024-05-16 17:00
- 2024-05-16 16:09
- 2024-05-16 10:13
- 2024-05-16 10:08
- 2024-05-16 09:44
- 2024-05-16 07:56
Roche Shares Climb After Weight-Loss Drug Shows Efficacy in Early-Stage Trial(The Wall Street Journal)
- 2024-05-16 07:55
Dow Jones Futures Rise On Cisco, Walmart After Market Rally Hits Highs, Nvidia Breaks Out(Investor's Business Daily)
- 2024-05-16 07:15
- 2024-05-16 07:03
- 2024-05-16 06:58
Technical Assessment: Bullish in the Intermediate-Term(Argus Research)
- 2024-05-16 06:52
- 2024-05-16 06:45
- 2024-05-16 01:09
- 2024-05-16 00:03
Page 1 of 10
previousnext